skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.6.0

Summary

Query: Party Name contains all words: U.S. PHARMACEUTICALS, INC.
Number of results: 53
Results are in reverse chronological order

Page #1. 2 3 Next
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
91297965
03/31/2025
Kurasek, Christian F.
Mark: MODERALL S#:98339338
Takeda Pharmaceuticals U.S.A., Inc.
Mark: ADDERALL S#:74527272 R#:1908092
Mark: ADDERALL XR S#:85201629 R#:4005685
98363580
03/26/2025
Global Alliance Trading Co. LLC
Mark: AGRIFEN S#:98363580
Takeda Pharmaceuticals U.S.A., Inc.
98339338
01/29/2025
Kurasek, Christian F.
Mark: MODERALL S#:98339338
Takeda Pharmaceuticals U.S.A., Inc.
98414251
12/27/2024
EyePoint Pharmaceuticals US, Inc.
Mark: DURAJECT S#:98414251
97882308
12/23/2024
Guangzhou Baiwei Technology Co., Ltd. 
Mark: ACTIVE PRO S#:97882308
Taro Pharmaceuticals U.S.A., Inc.
98331613
07/19/2024
Hi-Tech Pharmaceuticals, Inc.
Mark: PROAKTIV S#:98331613
Taro Pharmaceuticals U.S.A., Inc.
79365659
07/10/2024
ADOCIA
Mark: ADORAL S#:79365659
Takeda Pharmaceuticals U.S.A., Inc.
98451125
06/11/2024
ALLERGAN HOLDINGS FRANCE SAS
Mark: ILLUMID S#:98451125
Taro Pharmaceuticals U.S.A., Inc.
Sun Pharmaceutical Industries Limited
97724847
11/30/2023
EyePoint Pharmaceuticals US, Inc.
Mark: RETIVU S#:97724847
Eli Lilly and Company
97724835
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAMAC S#:97724835
Novartis AG
97767088
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAVUE S#:97767088
Novartis AG
98048453
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURVUE S#:98048453
Novartis AG
98048464
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURVIEW S#:98048464
Novartis AG
98073717
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAVYU S#:98073717
Novartis AG
97724740
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAVU S#:97724740
Novartis AG
97724877
11/27/2023
EyePoint Pharmaceuticals US, Inc.
Mark: RYVIZ S#:97724877
JOHNSON & JOHNSON
98048432
11/13/2023
EyePoint Pharmaceuticals US, Inc.
Mark: OPVUE S#:98048432
Indivior Inc.
97724775
11/13/2023
EyePoint Pharmaceuticals US, Inc.
Mark: OPVU S#:97724775
Indivior Inc.
91286194
07/21/2023
Kyon Biotech AG
Mark: ARGULIN S#:97160775
Takeda Pharmaceuticals U.S.A., Inc.
Mark: AGRYLIN S#:78609806 R#:3119751
97160775
02/21/2023
Kyon Biotech AG
Mark: ARGULIN S#:97160775
Takeda Pharmaceuticals U.S.A., Inc.
91283429
02/15/2023
Bonnie M. Shanser
Mark: RESTORATIVE ELEMENTS S#:97169327
Taro Pharmaceuticals U.S.A., Inc.
Mark: RESTORATIVE ELEMENTS S#:90453041 R#:6733073
97169327
11/14/2022
Shanser, Bonnie M.
Mark: RESTORATIVE ELEMENTS S#:97169327
Taro Pharmaceuticals U.S.A., Inc.
91264867
09/16/2020
Alchemyhealth Inc.
Mark: ADDERZOL XR S#:88754787
Takeda Pharmaceuticals U.S.A., Inc.
Mark: ADDERALL S#:74527272 R#:1908092
Mark: ADDERALL XR S#:85201629 R#:4005685
88381334
03/11/2020
Spectrum Pharmaceuticals, Inc.
Mark: EXIANT S#:88381334
The Binding Site Group Limited
Takeda Pharmaceuticals U.S.A., Inc.
88167946
04/18/2019
EyePoint Pharmaceuticals US, Inc.
Mark: YUTIQ S#:88167946
Merck Sharp & Dohme Corp.
Page #1. 2 3 Next

Results as of 04/04/2025 08:04 PMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY